All News
Filter News
Found 808,679 articles
-
Seattle Genetics, Inc. Initiates Brentuximab Vedotin (SGN-35) Retreatment Clinical Trial
7/24/2009
-
AlphaRx Inc. Signs Cooperation Agreement with Venturepharm China
7/24/2009
-
OncoVista Innovative Therapies, Inc. Announces the Initiation of Clinical Development of AdnaGen's Breast Cancer Circulating Tumor Cells (CTCs) Diagnostic Technology in Women with High-Risk Locally Advanced Breast Cancer
7/24/2009
-
Immunomedics, Inc. Partners With Alexis Biotech to Develop Targeted Vaccines in Cancer and AIDS
7/24/2009
-
Calypso Medical Technologies and Varian Medical Systems Enter into Master Development Agreement for Radiation Therapy Cancer Treatment
7/24/2009
-
GlaxoSmithKline to Distribute Dr. Reddy's Laboratories Ltd.'s Generic Drugs in Developing Markets
7/24/2009
-
CHMP Recommends Expanded Use of ISENTRESS(R) (raltegravir), from Merck Sharp & Dohme, in Adult Patients with HIV-1 Infection
7/24/2009
-
Roche's Mabthera Receives Positive Opinion In Europe For Treating Patients Whose Chronic Lymphocytic Leukaemia Returns
7/24/2009
-
SpineAlign Medical, Inc. Treats First Patient in U.S. with New, Innovative System for Vertebral Compression Fracture Repair
7/24/2009
-
Smith & Nephew Inc. Release: United States Patent Office Issues Decision in Re-examination Proceedings
7/24/2009
-
Cytori Therapeutics, Inc. Comments on Patent Appeal
7/24/2009
-
United States Patent and Trademark Office Confirms Validity of Kinetic Concepts, Inc. Negative Pressure Wound Therapy Patents
7/24/2009
-
Elekta CMS Software Receives FDA 510(k) Clearance for Monaco VMAT Treatment Planning Solution
7/24/2009
-
OncoGenex Pharmaceuticals Inc. Completes $9.5 Million Registered Direct Offering
7/24/2009
-
Cyclacel Pharmaceuticals, Inc. to Raise Up to $5.9 Million in Registered Direct Offering
7/24/2009
-
CytRx Corporation Announces $20 Million Registered Direct Offering
7/24/2009
-
SemBioSys Genetics Inc. Completes Public Offering
7/24/2009
-
BioElectronics Corporation Significantly Reduces Convertible Debt Levels
7/24/2009
-
Antares Pharma, Inc. Announces Pricing of Securities Offering
7/24/2009
-
Gamma Pharmaceuticals Announces Change in Trading Venue
7/24/2009